同种异体脂肪基质临床应用与适应症的系统综述
该系统综述通过检索PubMed/MEDLINE/Cochrane/Embase,纳入截至2024年5月30日的人与动物研究,评估同种异体脂肪基质(AAM)在软组织填充中的应用与结局。共纳入10项人体研究和9项动物研究,人体研究包含93例患者。AAM注射后体积保留率为21.5%至100%,最常见并发症为红斑、肿胀、注射点疼痛和烧灼感,均易缓解,患者满意度为72.9%至100%。
要点
- AAM可用于足部、手背、腹部、臀部、颞部、乳房、生殖器、压疮及面部年轻化等多种软组织填充。
- 人体研究中AAM注射物体积保留率范围为21.5%至100%,患者满意度为72.9%至100%。
- 常见并发症为红斑、肿胀、注射点疼痛和烧灼感,均易缓解。
核心结论
- AAM是软组织填充的有前景生物材料,组织学分析支持其促进脂肪生成和新生血管形成的作用。
研究设计与样本
- 系统综述通过PubMed/MEDLINE/Cochrane/Embase检索,截至2024年5月30日,纳入10项人体研究和9项动物研究。
- 人体研究共包含93例患者。
主要发现
- AAM适应症包括足部和手背年轻化、腹部和臀部塑形、颞部萎缩、乳房和生殖器增大、压疮及面部年轻化。
- AAM注射体积各异,体积保留率范围为21.5%至100%。
- 最常见并发症为红斑、肿胀、注射点疼痛和烧灼感,均易缓解。
- 患者满意度评分范围为72.9%至100%。
- 动物研究表明AAM与自体脂肪、富血小板血浆或合成支架联合治疗可增强效果。
临床怎么用
- AAM可作为软组织填充的备选生物材料,适用于多种部位。
- 临床应用中需注意注射体积和部位,关注体积保留率范围。
- 常见并发症轻微且易缓解,患者满意度较高。
局限性
- 需要进一步研究优化脱细胞方案并改善生物活性和组织整合。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Autologous fat transfer remains a staple in aesthetic and reconstructive surgery because of its regenerative capacity and tissue integration. However, limitations such as donor-site morbidity and unpredictable volume retention persist. Allograft adipose matrix (AAM), a product made from human fat tissue that serves as a natural scaffold to promote adipogenesis, offers a promising alternative, serving as a scaffold for adipogenesis and delivering key extracellular matrix components. This review examines clinical applications and outcomes in soft-tissue augmentation. METHODS: A systematic review was conducted by means of PubMed/MEDLINE/Cochrane/Embase using "allograft adipose matrix," "decellularized adipose matrix," "Renuva," and "Leneva." Studies published up to May 30, 2024, involving human or animal AAM treatment, were included. Data on demographics, clinical use, injection protocols, outcomes, volume retention, and complications were extracted and analyzed. RESULTS: From 352 studies, 10 involving humans and 9 involving animals were included. Human studies included 93 patients. Indications for AAM included foot and dorsal hand rejuvenation, abdominal and buttocks contouring, temple atrophy, breast and genitalia augmentation, pressure ulcers, and facial rejuvenation. AAM injection volumes varied, with retention rates ranging from 21.5% to 100%. The most common complications were erythema, swelling, injection-site pain, and burning, all resolving easily. Patient satisfaction scores ranged from 72.9% to 100%. CONCLUSIONS: AAM provides a promising biomaterial for soft-tissue augmentation. Histologic analysis supports its role in adipogenesis and neovascularization. Animal studies suggest enhancements through combination therapies, including AAM with autologous fat, platelet-rich plasma, or synthetic scaffolds. Further research is needed to optimize decellularization protocols and improve bioactivity and tissue incorporation.
引用
- Morel SBA, Vranis N, Perez J, et al. Current Applications and Indications of Allograft Adipose Matrix: A Systematic Review. Plast Reconstr Surg. 2025. PMID: 41056060. doi:10.1097/PRS.0000000000012506
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。